Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-12

Clinical Trial Update: The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pancreatic polypeptide's effect on insulin requirements in Type 1 diabetes and post-pancreatectomy diabetes was terminated; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pancreatic polypeptide (pancreatic polypeptide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: TERMINATED | Results posted: 2017-07-12